Failure of infused beta-hydroxybutyrate to decrease proteolysis in man.
about
Increased proteolysis. An effect of increases in plasma cortisol within the physiologic rangeQuantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetesDifferential effects of insulin deficiency on albumin and fibrinogen synthesis in humans.Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo.Effect of beta-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humansNutrient interactions with reference to amino acid and protein metabolism in non-ruminants; particular emphasis on protein-energy relations in man.Regulation of protein turnover in skeletal and cardiac muscle.Clinical review: ketones and brain injury.Effect of ketone bodies on glucose production and utilization in the miniature pig.Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.Influence of fatty acids on ammonia and amino acid flux from active human muscle.Apparent decreased oxidation and turnover of leucine during infusion of medium-chain triglycerides.Ketone-body metabolism in tumour-bearing rats.Blockade of fatty acid oxidation mimics phase II-phase III transition in a fasting bird, the king penguin.Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans.Effects of insulin on whole body and forearm leucine and KIC metabolism in type 1 diabetes.Metabolic and neurologic effects of an intravenous medium-chain triglyceride emulsion.Increased leucine flux in short-term fasted human subjects: evidence for increased proteolysis.
P2860
Q24563463-9E554B07-4291-4B02-A859-25BA00893A1DQ30982692-4F4D9D27-25A6-4073-85E7-70FB5BFF11EDQ34197587-78F6132D-39E8-4D57-BEBD-98D00543B066Q34521538-906F2C10-7E69-4AB6-92F4-8A4DA8E71B58Q34557322-2579BAB5-0E34-49F7-88D7-0028D86CAA2EQ36949326-AE220004-D757-4725-B7C5-2C5A4B381EE2Q37628846-33239E54-1C3E-4D09-BEB8-CF3F08B7E9C1Q37864740-46236159-9834-4F65-B8D9-0F5DD0A18E88Q40926091-E5B1E235-2120-4F46-ABCA-466DB22BEE1AQ41104002-CAAD1279-606B-48C9-9B87-0DE4BA84CE42Q41158325-56C54732-A173-4650-9497-C9FF5B058543Q41486548-A91A1633-88E7-47BB-A2C5-A19DA25F8B0AQ42263613-AB7B17EB-EB44-4732-AF1C-AD2F4B115CC1Q44031653-9FC3CEF4-D09C-46CC-A687-6A51FC5D5DDDQ44271320-0698D6BA-02FB-4561-9853-A953B52534F7Q44305032-64AA13E0-B9C3-4158-992C-1E0D5A688DB1Q50874251-970C1324-DC66-4D7B-9118-634ED35C4D0EQ51641436-042123A1-8E9F-465B-8AC8-4AA421A1345B
P2860
Failure of infused beta-hydroxybutyrate to decrease proteolysis in man.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Failure of infused beta-hydroxybutyrate to decrease proteolysis in man.
@en
type
label
Failure of infused beta-hydroxybutyrate to decrease proteolysis in man.
@en
prefLabel
Failure of infused beta-hydroxybutyrate to decrease proteolysis in man.
@en
P2093
P356
P1433
P1476
Failure of infused beta-hydroxybutyrate to decrease proteolysis in man.
@en
P2093
P304
P356
10.2337/DIAB.32.3.197
P407
P577
1983-03-01T00:00:00Z